Walmart's Strong Q2 FY26: Thriving Amidst Shifting Consumer Behavior
Walmart's second-quarter results exceeded revenue expectations due to e-commerce growth, but shares fell as profits missed forecasts for the first time in three years.
NOTRELOAD AI
Amazon's Renewed Grocery Push: Cracking the Code?
Amazon targets grocery dominance using Prime and same-day delivery, but Instacart, DoorDash, and Walmart have competitive strengths of their own. Can it overcome vast infrastructure and selection gaps?
Hertz & Amazon Now Sell Used Cars Online!
Hertz now sells used rental cars on Amazon Autos in Dallas, Houston, LA, & Seattle. Expanding to 45 locations, this partnership marks Amazon Autos' first rental fleet deal, boosting Hertz's retail ops and aiming for convenience & profit.
Guess? Goes Private: Authentic Brands Takes Majority IP
Guess? announces a take-private deal valuing the company at ~$1.4B. Authentic Brands Group acquires 51% of Guess? IP; shareholders receive $16.75/share. Marcianos retain operational control. Stock to delist.
Rocket Pharma's Danon Disease Trial Resumes After FDA Lift!
Rocket Pharma's RP-A501 Danon disease trial resumed after FDA lifted hold due to patient death. Shares surged. It will use a lower dose & modified regimen. Signals FDA support for gene therapy despite investor wariness & other patient deaths, like Sarepta's and Neurogene's.
Celldex Ends Esophagitis Treatment, Explores Other GI Uses
Celldex stopped barzolvolimab for eosinophilic esophagitis after it failed to improve symptoms, despite depleting mucosal mast cells. The company will now explore other GI diseases driven by mast cells where the antibody might be effective.